AlphaFold predicted structure
DPH2 · Q9BQC3

Mean pLDDT
83.3/ 100
Confident
489 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)28%
- Low(50–70)12%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
diphthamide biosynthesis 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Intellectual disability
BIALLELIC, autosomal or pseudoautosomaldevelopmental delay with short stature, dysmorphic facial features, and sparse hair 2
neurodegenerative disease
developmental delay with short stature, dysmorphic facial features, and sparse hair 1
Global developmental delay
Short stature
ventricular septal defect
Intellectual disability
Macrocephaly
hepatocellular carcinoma
cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2
Required for the first step of diphthamide biosynthesis, a post-translational modification of histidine which occurs in elongation factor 2 (PubMed:32576952). DPH1 and DPH2 transfer a 3-amino-3-carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to a histidine residue, the reaction is assisted by a reduction system comprising DPH3 and a NADH-dependent reductase (By similarity). Facilitates the reduction of the catalytic iron-sulfur cluster found in the DPH1 subunit (By similarity)
DPH2 · Q9BQC3

Mean pLDDT
83.3/ 100
Confident
489 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0